(Q63335122)
Statements
A Multicenter, Double-Blind, 58 Week Rollover Study to Assess the Safety and Tolerability of BMS-820836 in Patients With Treatment Resistant Major Depression (English)
0 references
August 2011
0 references
October 2013
0 references
789
0 references
18 year
0 references
65 year
0 references